Shift in Focus: Public Health Campaigns and E-Cigarettes

Aug.19.2022
Shift in Focus: Public Health Campaigns and E-Cigarettes
Anti-tobacco movement shifts focus to e-cigarettes as public health funds and attention pivot, experts say. (Source: AAP)

The anti-tobacco movement has waned, with a new report showing a shift in funding and attention towards public health efforts and electronic cigarettes. A new study published in the Australia and New Zealand Public Health Journal interviewed 31 experts, including tobacco control advocates and health professionals, who expressed the need for new information and funding to address the stagnant movement.


Experts say that as attention shifts to electronic cigarettes, the anti-smoking movement is falling behind. (Photo by Joel Carrett/AAP)


Michelle Jongenelis from the University of Melbourne stated, "In order to reach Australia's goal of reducing smoking rates to below 5% by 2030 and lessen the burden on the healthcare system by tobacco, we need to invest in effective methods." She commented, "Despite evidence showing that strong mass media campaigns targeting tobacco harm are crucial in reducing smoking rates, Australia's investment in such campaigns falls below standards and has notably decreased.


Dr. Jongenelis states that experts who engaged in a conversation with her are calling for an updated, evidence-based national strategy to aid smokers quit. She cautions that any reforms must be safeguarded from the influence of lobbying groups exploiting legal loopholes.


We are battling a powerful tobacco industry that continues to hinder efforts to reduce smoking," said the researchers.


They claim to desire a smoke-free world, but this is merely an attempt to legalize their activities, while they continue to spend billions promoting tobacco cigarettes. They are exploiting loopholes in our legislation, lobbying policymakers to relax laws so they can continue to sell a product that causes millions of deaths worldwide every year," said Dr. Jongenelis.


Statement


This article is compiled based on information from a third-party source and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of its contents. The translation of this article is for industry communication and research purposes only.


Due to limitations in translation capabilities, this article may not fully express the same meaning as the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete consistency with the Chinese government's position and statements on any domestic, Hong Kong, Macau, Taiwan, or foreign affairs.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Thai Research describes e-cigarettes as a “first gateway” for ages 15–20, linked to appearance and flavors
Thai Research describes e-cigarettes as a “first gateway” for ages 15–20, linked to appearance and flavors
A Thai report says Minister attached to the Prime Minister’s Office Santi Piyatat is advancing efforts toward a vape-free society. On Jan. 12, a seminar at the Thai Health Promotion Foundation’s learning center presented a study covering six regions of Thailand on spending related to cigarettes and e-cigarettes and the behavior of different smoker groups.
Jan.13 by 2FIRSTS.ai
Japan Tobacco Launches Limited-Edition “Purple Dusk” Colorway for Ploom AURA, Priced at JPY 2,980
Japan Tobacco Launches Limited-Edition “Purple Dusk” Colorway for Ploom AURA, Priced at JPY 2,980
Japan Tobacco has launched the fourth installment of its limited-color series for the Ploom AURA heated-tobacco device, unveiling “Purple Dusk” . Priced at JPY 2,980 (about USD 18.7, tax included), it goes on limited early sale via official channels from Jan 13, before rolling out to convenience stores and other retail outlets across Japan from Jan 20.
Jan.13 by 2FIRSTS.ai
SICPA Secures Five-Year UK Vape Tax Stamp Contract
SICPA Secures Five-Year UK Vape Tax Stamp Contract
HM Revenue and Customs (HMRC) has awarded a five-year contract to Swiss technology company SICPA and Cartor Security Printers to implement the United Kingdom’s new vaping duty stamp and track-and-trace system, beginning in April 2026.
Market
Feb.24
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
Turning Point Brands, a U.S. nicotine and tobacco-related consumer products company, reported its fiscal 2025 fourth-quarter results: quarterly revenue was $121 million, up 29% year over year; adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) was $30 million, up 14%. Net revenue from modern oral nicotine products was $41.3 million, up 266% year over year.
Mar.03 by 2FIRSTS.ai
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.
Special Report
Mar.03
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai